BioLife Solutions to Report Second Quarter 2024 Financial Results and Business Update on August 8, 2024
BioLife Solutions Is Maintained at Buy by TD Cowen
BioLife Solutions Price Target Raised to $26.00/Share From $20.00 by TD Cowen
BioLife Solns Analyst Ratings
TD Cowen Maintains BioLife Solutions(BLFS.US) With Buy Rating, Maintains Target Price $26
Express News | BioLife Solutions Inc : TD Cowen Raises Target Price to $26 From $20
TD Cowen Maintains BioLife Solutions(BLFS.US) With Buy Rating, Raises Target Price to $26
BioLife Solutions: Strong Buy Rating on Robust Gross Margins and Positive Long-Term EBITDA Outlook
BioLife Solutions, Inc. (NASDAQ:BLFS): When Will It Breakeven?
BioLife Solutions(BLFS.US) Officer Sells US$63,090 in Common Stock
CellFE Announces Addition of Life Science Tools Veteran Mike Rice to Board of Directors
A Look At The Intrinsic Value Of BioLife Solutions, Inc. (NASDAQ:BLFS)
Insider Sale: Todd Berard Sells 10,000 Shares of BioLife Solutions Inc (BLFS)
BioLife Solutions(BLFS.US) Officer Sells US$201.8K in Common Stock
Northland Securities Maintains BioLife Solutions(BLFS.US) With Buy Rating, Maintains Target Price $26
BioLife Solutions (NASDAQ:BLFS) Dips 5.5% This Week as Increasing Losses Might Not Be Inspiring Confidence Among Its Investors
BioLife Solutions (BLFS) Receives a Buy From Craig-Hallum
BioLife Solutions Introduces the CellSeal CryoCase at International Society for Cell & Gene Therapies (ISCT) Conference in Vancouver
Insider Sale: Chief Marketing Officer Todd Berard Sells 10,000 Shares of BioLife Solutions Inc ...
BioLife Solutions(BLFS.US) Officer Sells US$226.7K in Common Stock